Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

Cited by (1,006)

Items 401–500 of 1,006

1. Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice
   Lamb, B. · 1997 · Human Molecular Genetics
2. Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D
   Uri S. Ladror, Seth W. Snyder, G.T. Wang, Thomas F. Holzman, Grant A. Krafft · 1994 · Journal of Biological Chemistry
3. Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer’s Disease
   Md. Sahab Uddin, Md. Tanvir Kabir, Md. Sohanur Rahman, Tapan Behl, Philippe Jeandet, Ghulam Md Ashraf, Agnieszka Najda, May Nasser Bin-Jumah, Hesham Rushdey El-Seedi, Mohamed M. Abdel‐Daim · 2020 · International Journal of Molecular Sciences
4. BACE1 and BACE2 enzymatic activities in Alzheimer’s disease
   Rachel R. Ahmed, Christopher J. Holler, Robin L. Webb, Feng Li, Tina L. Beckett, Michael Paul Murphy · 2009 · Journal of Neurochemistry
5. The role of membrane trafficking in the processing of amyloid precursor protein and production of amyloid peptides in Alzheimer's disease
   Jing Zhi Anson Tan, Paul A. Gleeson · 2019 · Biochimica et Biophysica Acta (BBA) - Biomembranes
6. Enhanced Release of Amyloid -Protein from Codon 670/671 Swedish Mutant -Amyloid Precursor Protein Occurs in Both Secretory and Endocytic Pathways
   Ruth G. Perez, Sharon L. Squazzo, Edward H. Koo · 1996 · Journal of Biological Chemistry
7. hnRNP C increases amyloid precursor protein (APP) production by stabilizing APP mRNA
   Lakshman E. Rajagopalan, Cara J. Westmark, Jason A. Jarzembowski, James S. Malter · 1998 · Nucleic Acids Research
8. Increased antioxidant enzyme activity in amyloid beta protein-resistant cells
   Yutaka Sagara, Richard Dargusch, F. George Klier, David A. Schubert, Christian Behl · 1996 · Journal of Neuroscience
9. The Biological and Pathological Function of the Presenilin-1 ΔExon 9 Mutation Is Independent of Its Defect to Undergo Proteolytic Processing
   Harald Steiner, Helmut Romig, Melissa G. Grim, Uwe Philipp, Brigitte Pesold, Martin Citron, Ralf Baumeister, Christian Haass · 1999 · Journal of Biological Chemistry
10. BACE inhibition-dependent repair of Alzheimer’s pathophysiology
    Keskin, Aylin D., Kekuš, Maja, Adelsberger, Helmuth, Neumann, Ulf, Shimshek, Derya R., Song, Beomjong, Zott, Benedikt, Peng, Tingying, Förstl, Hans, Staufenbiel, Matthias et al. · 2017 · Proceedings of the National Academy of Sciences
11. The human NACP/α-synuclein gene: chromosome assignment to 4q21.3–q22 and TaqI RFLP analysis
    Xiaohua Chen, H.A.Rohan de Silva, Mark J. Pettenati, P. Nagesh Rao, Peter St George‐Hyslop, Allen D. Roses, Yu Xia, Karen J. Horsburgh, Kenji Uéda, Tsunao Saitoh · 1995 · Genomics
12. NFκB-dependent Control of BACE1 Promoter Transactivation by Aβ42
    Virginie Buggia-Prévot, Jean Sévalle, Steffen Roßner, Frédéric Checler · 2008 · Journal of Biological Chemistry
13. Control of APP processing and Aβ generation level by BACE1 enzymatic activity and transcription
    Yu Li, Weihui Zhou, Yigang Tong, Guiqiong He, Weihong Song · 2006 · The FASEB Journal
14. Transient receptor potential channels in Alzheimer's disease
    Shinichiro Yamamoto, Teruaki Wajima, Yuji Hara, Motohiro Nishida, Yasuo Mori · 2007 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
15. Alzheimer’s disease due to loss of function: A new synthesis of the available data
    Kasper P. Kepp · 2016 · Progress in Neurobiology
16. Regulation and Expression of the Alzheimer's β/A4 Amyloid Protein Precursor in Health, Disease, and Down's Syndromea
    Konrad T. Beyreuther, Peter Pollwein, Gerd Multhaup, Ursula Mönning, GERHARD KÖNIG, Thomas Dyrks, WALTER J. SCHUBERT, Colin Louis Masters · 1993 · Annals of the New York Academy of Sciences
17. The Early Events That Initiate β-Amyloid Aggregation in Alzheimer’s Disease
    Xingyu Zhang, Zhihui Fu, Lanxia Meng, Mingyang He, Zhentao Zhang · 2018 · Frontiers in Aging Neuroscience
18. Requirement of PEN-2 for Stabilization of the Presenilin N-/C-terminal Fragment Heterodimer within the γ-Secretase Complex
    Stefan Prokop, Keiro Shirotani, Dieter Edbauer, Christian Haass, Harald Steiner · 2004 · Journal of Biological Chemistry
19. Hereditary Cerebral Hemorrhage with Amyloidosis‐Dutch Type (HCHWA‐D): I ‐ A Review of Clinical, Radiologic and Genetic Aspects
    Marjolijn Bornebroek, Joost Haan, Marion L. C. Maat–Schieman, Sjoerd G. van Duinen, Raymund A.C. Roos · 1996 · Brain Pathology
20. Interaction of Presenilins with the Filamin Family of Actin-Binding Proteins
    Wanjiang Zhang, Sang Woo Han, Daniel W. McKeel, Alison Goate, Jane Y. Wu · 1998 · Journal of Neuroscience
21. The Solvent Protection of Alzheimer Amyloid-β-(1–42) Fibrils as Determined by Solution NMR Spectroscopy
    Anders Olofsson, A.E. Sauer-Eriksson, Anders Öhman · 2005 · Journal of Biological Chemistry
22. Alzheimer's Disease and the Amyloid β-Protein
    Dominic M. Walsh, David B. Teplow · 2012 · Progress in molecular biology and translational science
23. Nuclear Factor-κB Regulates βAPP and β- and γ-Secretases Differently at Physiological and Supraphysiological Aβ Concentrations
    Linda Chami, Virginie Buggia-Prévot, Eric Duplan, Dolores Delprete, Mounia Chami, Jean‐François Peyron, Frédéric Checler · 2012 · Journal of Biological Chemistry
24. Reducing Amyloid Plaque Burden via Ex Vivo Gene Delivery of an Aβ-Degrading Protease: A Novel Therapeutic Approach to Alzheimer Disease
    Matthew L. Hemming, Michaela Patterson, Casper Reske-Nielsen, Ling Lin, Ole Isacson A, Dennis J. Selkoe · 2007 · PLoS Medicine
25. Untitled work
    2008 · 10.1074/jbc.m801487200
26. New clues to Alzheimer's disease: Unraveling the roles of amyloid and tau
    Bruce A. Yanker · 1996 · Nature Medicine
27. The Creatine Kinase/Creatine Connection to Alzheimer′s Disease: CK Inactivation, APP‐CK Complexes and Focal Creatine Deposits
    Tanja S. Bürklen, Uwe Schlattner, Ramin Homayouni, Kathleen M. Gough, Margaret Rak, Adriana Viorica Szeghalmi, Theo Wallimann · 2006 · BioMed Research International
28. Intracellular routing of human amyloid protein precursor: Axonal delivery followed by transport to the dendrites
    Mikael Simons, Elina Ikonen, Pentti J. Tienari, Angel Cid Arregui, U. Mönning, Konrad T. Beyreuther, C. G. Dotti · 1995 · Journal of Neuroscience Research
29. An ultrasensitive electrochemical aptasensor for early diagnosis of Alzheimer’s disease, using a fern leaves-like gold nanostructure
    Masoud Negahdary, H. Heli · 2019 · Talanta
30. Impairments of long-term potentiation in hippocampal slices of β-amyloid-infused rats
    Akio Itoh, Tadashi Akaike, Masahiro Sokabe, Atsumi Nitta, Ryuichi Iida, Ana Olariu, Kiyofumi Yamada, Toshitaka Nabeshima · 1999 · European Journal of Pharmacology
31. Amyloidogenic Processing of Amyloid Precursor Protein: Evidence of a Pivotal Role of Glutaminyl Cyclase in Generation of Pyroglutamate-Modified Amyloid-β
    Holger Cynis, Eike Scheel, Takaomi C. Saido, Stephan Schilling, Hans‐Ulrich Demuth · 2008 · Biochemistry
32. β‐Secretase‐1 elevation in transgenic mouse models of Alzheimer’s disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development
    Xue‐Mei Zhang, Yan Cai, Kun Xiong, Huaibin Cai, Xuegang Luo, Jiachun Feng, Richard W. Clough, Robert G. Struble, Peter R. Patrylo, Xiao‐Xin Yan · 2009 · European Journal of Neuroscience
33. Anticonvulsants attenuate amyloid β-peptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathology
    Robert J. Mark, John Wesson Ashford, Yadong Goodman, Mark P. Mattson · 1995 · Neurobiology of Aging
34. Genetics of neurodegenerative diseases: an overview
    Lasse Pihlstrøm, Sarah Wiethoff, Henry Houlden · 2017 · Handbook of clinical neurology
35. From brain to food: Analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin–plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry
    Marcus O.W. Grimm, Sven Grösgen, Markus J. Riemenschneider, Heikki Tanila, Heike S. Grimm, Tobias Hartmann · 2011 · Journal of Chromatography A
36. Biomarkers of neurodegenerative disorders: How good are they?
    Varun Rachakonda, Tian Hong Pan, Wei Dong Le · 2004 · Cell Research
37. Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer’s disease
    Shinohara, Mitsuru, Fujioka, Shinsuke, Murray, Melissa E., Wojtas, Aleksandra, Baker, Matthew, Rovelet-Lecrux, Anne, Rademakers, Rosa, Das, Pritam, Parisi, Joseph E., Graff-Radford, Neill R. et al. · 2014 · Brain
38. Amyloid-β Production: Major Link Between Oxidative Stress and BACE1
    Elena Tamagno, Michela Guglielmotto, Debora Monteleone, Massimo Tabaton · 2011 · Neurotoxicity Research
39. Soluble Arctic amyloid β protein inhibits hippocampal long‐term potentiation in vivo
    Igor V. Klyubin, Dominic M. Walsh, William K. Cullen, Julia V. Fadeeva, Roger Anwyl, Dennis J. Selkoe, Michael J. Rowan · 2004 · European Journal of Neuroscience
40. Amyloid precursor protein mutation E682K at the alternative β‐secretase cleavage β′‐site increases Aβ generation†
    Lujia Zhou, Nathalie Brouwers, Iryna Benilova, Annelies Vandersteen, Marc H. Mercken, Koen Van Laere, Philip Van Damme, David Demedts, Fred VAN LEUVEN, Kristel Sleegers et al. · 2011 · EMBO Molecular Medicine
41. Cell-type and Amyloid Precursor Protein-type Specific Inhibition of Aβ Release by Bafilomycin A1, a Selective Inhibitor of Vacuolar ATPases
    Jeroen Knops, Susanna Suomensaari, Michael Lee, Lisa McConlogue, Peter A. Seubert, Sukanto Sinha · 1995 · Journal of Biological Chemistry
42. Alzheimer Disease: from Molecular Biology to Therapy
    Ezio Giacobini · 1997 · Biomedicine & Pharmacotherapy
43. Health effects of aluminum: a critical review with emphasis on aluminum in drinking water
    Evert Nieboer, Brian L. Gibson, Andrew David Oxman, James R. Kramer · 1995 · Environmental Reviews
44. ?-sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood-brain barrier permeability and resistance to proteolytic degradation in plasma
    Joseph F. Poduslo, Geoffry L. Curran, Asok R. Kumar, Blas Frangione, Claudio A. Soto · 1999 · Journal of Neurobiology
45. A non‐amyloidogenic function of BACE‐2 in the secretory pathway
    Fluhrer, Regina, Capell, Anja, Westmeyer, Gil, Willem, Michael, Hartung, Bianka, Condron, Margaret M., Teplow, David B., Haass, Christian, Walter, Jochen · 2002 · Journal of Neurochemistry
46. Apolipoprotein E, Amyloid, and Alzheimer Disease
    Kelly R. Bales · 2002 · Molecular Interventions
47. Regulation of β-amyloid precursor protein isoform mRNAs by transforming growth factor-β1 and interleukin-1β in astrocytes
    Carol W. Gray, Ambrish J. Patel · 1993 · Molecular Brain Research
48. Cloning of the cDNA encoding human brain trypsinogen and characterization of its product
    Ulrich K. Wiegand, Sabine Corbach, Annette Minn, Kang Jie, Benno Müller‐Hill · 1993 · Gene
49. Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice.
    Frank M. LaFerla, C K Hall, Lien T. Ngo, Gregory D. Jay · 1996 · Journal of Clinical Investigation
50. Hereditary Amyloid Cardiomyopathy Caused by a Variant Apolipoprotein A1
    Kamran Hamidi Asl, Juris J. Liepnieks, Kamran Hamidi Asl, Tomoyuki Uemichi, Georges Moulin, Emmanuel Desjoyaux, ROBERT LOIRE, Marc Delpech, Gilles Grateau, Merrill D. Benson · 1999 · American Journal Of Pathology
51. Alzheimer's disease and soluble Aβ
    Thomas Wısnıewskı, Jorge A. Ghiso, Blas Frangione · 1994 · Neurobiology of Aging
52. Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5
    Feng Liu, Su Yuan, Baolin Li, Yan Zhou, John W. Ryder, Patricia A. Gonzalez‐DeWhitt, Patrick C. May, Binhui Ni · 2003 · FEBS Letters
53. Prevalence, incidence and duration of Braak's stages in the general population: can we know?
    Duyckaerts, C, Hauw, J.-J · 1997 · Neurobiology of Aging
54. The NACP/synuclein gene: chromosomal assignment and screening for alterations in Alzheimer disease
    Dominique Campion, Cosette Martin, Roland Heilig, Françoise Charbonnier, Viviane Moreau, Jean‐Michel Flaman, Jean‐Louis Petit, Didier Hannequin, Alexis Brice, Thierry Frébourg · 1995 · Genomics
55. Amyloid‐β protein (Aβ) Glu11 is the major β‐secretase site of β‐site amyloid‐β precursor protein‐cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis
    Deng, Yu, Wang, Zhe, Wang, Ruitao, Zhang, Xiaozhu, Zhang, Shuting, Wu, Yili, Staufenbiel, Matthias, Cai, Fang, Song, Weihong · 2013 · European Journal of Neuroscience
56. Dimerization of β-Site β-Amyloid Precursor Protein-cleaving Enzyme
    Gil G. Westmeyer, Michael Willem, Stefan F. Lichtenthaler, Glenn J. Lurman, Gerd Multhaup, Irmgard Assfalg‐Machleidt, Karina Reiß, Paul Säftig, Christian Haass · 2004 · Journal of Biological Chemistry
57. Genetic cathepsin B deficiency reduces β-amyloid in transgenic mice expressing human wild-type amyloid precursor protein
    VIVIAN Y. H. HOOK, Mark S. Kindy, Thomas Reinheckel, Christoph Peters, Gregory Hook · 2009 · Biochemical and Biophysical Research Communications
58. Genes, models and Alzheimer's disease
    Paul F. Chapman, Agnieszka M. Falinska, Simon G. Knevett, Mark F. Ramsay · 2001 · Trends in Genetics
59. Alzheimer Aβ neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides
    Ma, Jianyi, Brewer, H.Bryan, Potter, Huntington · 1996 · Neurobiology of Aging
60. Synaptic Dysfunction in Alzheimer’s Disease
    Elena E. Marcello, Roberta Epis, Claudia Saraceno, Mónica Di Luca · 2012 · Advances in experimental medicine and biology
61. Genetics of Alzheimer disease in the pre- and post-GWAS era
    Nilüfer Ertekin‐Taner · 2010 · Alzheimer s Research & Therapy
62. Familial Alzheimer’s Disease Mutations in Presenilin Generate Amyloidogenic Aβ Peptide Seeds
    Sarah Veugelen, Takashi Saito, Takaomi C. Saido, Lucía Chávez‐Gutiérrez, Bart De Strooper · 2016 · Neuron
63. Neuronal Structure is Altered by Amyloid Plaques
    Tara L. Spires‐Jones, Bradley T. Hyman · 2004 · Reviews in the Neurosciences
64. Autoantibodies to Amyloid β-Peptide (Aβ) are Increased in Alzheimer's Disease Patients and Aβ Antibodies Can Enhance Aβ Neurotoxicity: Implications for Disease Pathogenesis and Vaccine Development
    Avindra Nath, Elizabeth Hall, Marnia Tuzova, Michael Dobbs, Melina Jones, Caroline Anderson, Jerold G. Woodward, Zhihong Guo, Weiming Fu, Richard J. Kryscio et al. · 2003 · NeuroMolecular Medicine
65. Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein
    Saoussen Ben Halima, Sabyashachi Mishra, Karuppiah Muruga Poopathi Raja, Michael Willem, Antonio Baici, Kai Simons, Oliver Brüstle, Philipp Koch, Christian Haass, Amedeo Caflisch et al. · 2016 · Cell Reports
66. Phosphorylation of the amyloid β-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity
    Sathish Kumar, Oliver Wirths, Kathrin Stüber, Patrick Wunderlich, Philipp Koch, Sandra Theil, Nasrollah Rezaei‐Ghaleh, Markus Zweckstetter, Thomas A. Bayer, Oliver Brüstle et al. · 2016 · Acta Neuropathologica
67. The dual face of microglia (M1/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases
    Samar F. Darwish, Abdullah M. M. Elbadry, Amir S. Elbokhomy, Ghidaa A. Salama, Rania M. Salama · 2023 · Frontiers in Aging
68. A highly insoluble state of Aβ similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice
    Ola Philipson, Per Hammarström, K. Peter R. Nilsson, Erik Portelius, Tommie Olofsson, Martin Ingelsson, Bradley T. Hyman, Kaj Blennow, Lars Lannfelt, Hannu Kalimo et al. · 2008 · Neurobiology of Aging
69. Glial Expression of the β-Amyloid Precursor Protein (APP) in Global Ischemia
    Richard B. Banati, Jochen Gehrmann, Christoph Wießner, Konstantin‐Alexander Hossmann, G. W. Kreutzberg · 1995 · Journal of Cerebral Blood Flow & Metabolism
70. Drosophila models of human neurodegenerative disease
    Ho Yin Edwin Chan, Nancy M. Bonini · 2000 · Cell Death and Differentiation
71. Generation of βA4 from the amyloid protein precursor and fragments thereof
    Thomas Dyrks, Elke Dyrks, U. Mönning, Britta Urmoneit, Jonathan D. Turner, Konrad T. Beyreuther · 1993 · FEBS Letters
72. Proteolytic Processing of Alzheimer's Disease βA4 Amyloid Precursor Protein in Human Platelets
    Qiao‐Xin Li, Genevieve M. Evin, David Henry Small, Gerd Multhaup, Konrad T. Beyreuther, Colin Louis Masters · 1995 · Journal of Biological Chemistry
73. The Tottori (D7N) and English (H6R) Familial Alzheimer Disease Mutations Accelerate Aβ Fibril Formation without Increasing Protofibril Formation
    Yukiko Hori, Tadafumi Hashimoto, Yosuke Wakutani, Katsuya Urakami, Kenji Nakashima, Margaret M. Condron, Satoshi Tsubuki, Takaomi C. Saido, David B. Teplow, Takeshi Iwatsubo · 2006 · Journal of Biological Chemistry
74. The involvement of mitogen‐activated protein (MAP) kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline
    Merav Yogev‐Falach, Tamar Amit, Orit Bar‐Am, Marta Weinstock, Moussa B. H. Youdim · 2002 · The FASEB Journal
75. Intracellular Accumulation of β-Amyloid in Cells Expressing the Swedish Mutant Amyloid Precursor Protein
    Bronwyn L. Martin, Gesine Schrader‐Fischer, Jorge A. Busciglio, Maraid Duke, Paolo Paganetti, Bruce A. Yankner · 1995 · Journal of Biological Chemistry
76. Recent Status of Nanomaterial Fabrication and Their Potential Applications in Neurological Disease Management
    Khwaja Salahuddin Siddiqi, Azamal Husen, Sayed Sartaj Sohrab, Mensur Osman Yassin · 2018 · Nanoscale Research Letters
77. Increased seizure threshold and severity in young transgenic CRND8 mice
    Robert A. Del Vecchio, Lisa H. Gold, Steven J. Novick, Gwen Wong, Lynn A. Hyde · 2004 · Neuroscience Letters
78. Review: Model Peptides and the Physicochemical Approach to β-Amyloids
    David G. Lynn, Stephen C. Meredith · 2000 · Journal of Structural Biology
79. The presenilin C‐terminus is required for ER‐retention, nicastrin‐binding and γ‐secretase activity
    Christoph Kaether, Anja Capell, Dieter Edbauer, Edith Winkler, Božidar Novak, Harald Steiner, Christian Haass · 2004 · The EMBO Journal
80. Nicotinic receptor–mediated protection against β-amyloid neurotoxicity
    Shun Shimohama, Takeshi Kihara · 2001 · Biological Psychiatry
81. Nature, nurture and neurology: gene–environment interactions in neurodegenerative disease
    Tara L. Spires‐Jones, Anthony John Hannan · 2005 · FEBS Journal
82. Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the β-amyloid peptide intracellularly in hippocampal and cortical neurons
    Valentina Echeverrı́a, Adriana Ducatenzeiler, E. Dowd, Juhani Jänne, S.M. Grant, Moshe Szyf, Francisco G. Wandosell, Jesús Ávila, Heike S. Grimm, Stephen B. Dunnett et al. · 2004 · Neuroscience
83. Amyloid β protein levels in cerebrospinal fluid are elevated in early‐onset Alzheimer's disease
    Tamiko Nakamura, Mikio Shoji, Yasuo Harigaya, 光法 渡辺, Kenji Hosoda, Tobun T. Cheung, Lillian M. Shaffer, Todd Eliot Golde, Linda H. Younkin, Steven G. Younkin et al. · 1994 · Annals of Neurology
84. Protective effect of N-glycan bisecting GlcNAc residues on -amyloid production in Alzheimer's disease
    Keiko Akasaka‐Manya, Hiroshi Manya, Yoko Sakurai, Bogusław S. Wójczyk, Yasunori Kozutsumi, Yuko Saito, Naoyuki Taniguchi, Shigeo Murayama, Steven L. Spitalnik, Tamao Endo · 2009 · Glycobiology
85. Transthyretin and the brain re-visited: Is neuronal synthesis of transthyretin protective in Alzheimer's disease?
    Xinyi Li, Joel N. Buxbaum · 2011 · Molecular Neurodegeneration
86. Apolipoprotein E4 Stimulates cAMP Response Element-binding Protein Transcriptional Activity through the Extracellular Signal-regulated Kinase Pathway
    Nobutaka Ohkubo, Noriaki Mitsuda, Michio Tamatani, Atsushi Yamaguchi, Young‐Don Lee, Toshio Ogihara, Michael Peter Vitek, Masaya Tohyama · 2001 · Journal of Biological Chemistry
87. Molecular Genetics of Alzheimer's Disease
    Robert F. Clark, Alison Goate · 1993 · Archives of Neurology
88. Behavior of neural stem cells in the Alzheimer brain
    Ben Waldau, Ashok Kumar Shetty · 2008 · Cellular and Molecular Life Sciences
89. Elevated vulnerability to oxidative stress‐induced cell death and activation of caspase‐3 by the Swedish amyloid precursor protein mutation
    Anne Eckert, Barbara Steiner, Celio A. Marques, Steffen Leutz, Helmut Romig, Christian Haass, Walter E. Müller · 2001 · Journal of Neuroscience Research
90. Neurodegeneration: diseases of the cytoskeleton?
    Cynthia T. McMurray · 2000 · Cell Death and Differentiation
91. Animal models of amyloid‐β‐related pathologies in Alzheimer’s disease
    Ola Philipson, Anna Lord, Astrid Gumucio, Paul W. O'Callaghan, Lars Lannfelt, Lars N. G. Nilsson · 2010 · FEBS Journal
92. The Membrane-Bound Aspartyl Protease BACE1: Molecular and Functional Properties in Alzheimer’s Disease and Beyond
    Bastian Dislich, Stefan F. Lichtenthaler · 2012 · Frontiers in Physiology
93. Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: Emphasis on Alzheimer's disease and Parkinson's disease
    John R. James, Agneta K. Nordberg · 1995 · Behavior Genetics
94. Degradation of Amyloid β-Protein by a Serine Protease-α2-Macroglobulin Complex
    Wei Qiao Qiu, Wolfgang Borth, Zhen Ye, Christian Haass, David B. Teplow, Dennis J. Selkoe · 1996 · Journal of Biological Chemistry
95. Role of neurotransmission in the regulation of amyloid β-protein precursor processing
    Roger M. Nitsch, John H. Growdon · 1994 · Biochemical Pharmacology
96. Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity
    Alfred T. Welzel, John E. Maggio, Ganesh M. Shankar, Dominic Walker, Beth L. Ostaszewski, Shaomin Li, Igor V. Klyubin, Michael J. Rowan, Peter A. Seubert, Dominic M. Walsh et al. · 2014 · Biochemistry
97. Axonal Degeneration in AD: The Contribution of Aβ and Tau
    Natalia Salvadores, Cristian Gerónimo‐Olvera, Felipe A. Court · 2020 · Frontiers in Aging Neuroscience
98. The amyloid‐β peptide and its role in Alzheimer's disease
    Andrew B. Clippingdale, John D. Wade, Colin James Barrow · 2001 · Journal of Peptide Science
99. Genetic variants in a haplotype block spanningIDE are significantly associated with plasma A?42 levels and risk for Alzheimer disease
    Nilüfer Ertekin‐Taner, Mariet Allen, Daniel J. Fadale, Leah Scanlin, Linda H. Younkin, Ronald Carl Petersen, Neill R. Graff‐Radford, Steven G. Younkin · 2004 · Human Mutation
100. Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice
     Marissa J. Schafer, Melissa J. Alldred, Sang H. Lee, Michael E. Calhoun, Eva Petkova, Paul M. Mathews, Stephen D. Ginsberg · 2014 · Neurobiology of Aging